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Abstract: Sanitization of nucleotide pools is essential for genome maintenance. Deoxyuridine
5′-triphosphate nucleotidohydrolase (dUTPase) is a key enzyme in this pathway since it catalyzes
the cleavage of 2′-deoxyuridine 5′-triphosphate (dUTP) into 2′-deoxyuridine 5′-monophosphate
(dUMP) and inorganic pyrophosphate. Through its action dUTPase efficiently prevents uracil
misincorporation into DNA and at the same time provides dUMP, the substrate for de novo
thymidylate biosynthesis. Despite its physiological significance, knock-out models of dUTPase
have not yet been investigated in mammals, but only in unicellular organisms, such as bacteria
and yeast. Here we generate CRISPR/Cas9-mediated dUTPase knock-out in mice. We find that
heterozygous dut +/− animals are viable while having decreased dUTPase levels. Importantly, we
show that dUTPase is essential for embryonic development since early dut −/− embryos reach the
blastocyst stage, however, they die shortly after implantation. Analysis of pre-implantation embryos
indicates perturbed growth of both inner cell mass (ICM) and trophectoderm (TE). We conclude that
dUTPase is indispensable for post-implantation development in mice.
Keywords: dUTPase; CRISPR/Cas9-mediated knock-out; blastocyst outgrowth; embryonic development
1. Introduction
The maintenance of genome integrity and faithful preservation of genomic information are crucial
for viability. Toward these goals, various DNA damage and repair pathways along with the regulation
of a well-balanced deoxynucleotide (dNTP) pool work hand in hand [1]. Nucleotide pools are
maintained by several families of dNTP hydrolyzing enzymes present in most organisms [2–5]. These
enzymes sanitize the nucleotide pool by removing nucleotide building blocks (dNTPs) that contain
erroneous bases from the polymerase action. The deoxyuridine 5′-triphosphate nucleotidohydrolase
(dUTPase) family of enzymes is responsible for the removal of dUTP from the nucleotide pool by
hydrolyzing it into dUMP and inorganic pyrophosphate [6–8]. The importance of this enzymatic
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action is evident in light of the fact that most DNA polymerases cannot distinguish 2′-deoxyuridine
5′-triphosphate (dUTP) and 2′-deoxythymidine 5′-triphosphate (dTTP) and will readily incorporate
the uracil analog if it is available in the cellular dNTP pool [9]. Through their enzymatic action
that generates 2′-deoxyuridine 5′-monophosphate (dUMP), dUTPases also feed into the de novo
thymidylate biosynthesis pathway by providing dUMP as the substrate for thymidylate synthase.
Two major families of dUTPases have evolved that are referred to as trimeric and dimeric dUTPases,
reflecting their corresponding quaternary structure [6,10–13].
Trimeric dUTPases are present in almost all free-living organisms with the notable exception of
trypanosomes. Subunits of these enzymes contain a beta-sheeted arrangement [6]. The three subunits
donate conserved sequence motifs to build the three active site of the dUTPase trimer [14–16]. This
family of dUTPases is characteristic for Archaea, Bacteria, and Eucarya. As such, mammalian species
also rely on the action of trimeric dUTPases to keep a well-balanced dUTP/dTTP ratio. Herpesviruses
encode an intriguing monomeric homolog of this dUTPase enzyme family [17], where the protein
sequence contains a species-specific insert to allow the construction of the usual beta-sheeted dUTPase
fold in a monomeric enzyme [18,19]. Dimeric dUTPases perform the same catalytic action, however,
the protein sequence and the alpha-helical protein fold are drastically different from those observed in
the trimeric dUTPase family [10,11].
Due to the highly significant enzymatic character of dUTPases, the essentiality of this enzyme
family was addressed in numerous different organisms. Knock-outs have been generated in several
bacteria: Escherichia coli [20] and Mycobacterium smegmatis [7]. Based on these studies it was argued that
the bacterial cells lacking dUTPase activity are not viable. However, genomic analysis of Archaea and
prokaryotes identified several species that lack dut, the dUTPase encoding gene [12]. These findings
indicate that the presence of dUTPases may not be a universal requirement in prokaryotes.
The physiological role and importance of dUTPase have also been addressed in eukaryotes.
In yeast, dUTPase knock-out was still viable, although this genotype led to a thymine auxotroph
phenotype [21]. In Caenorhabditis elegans, RNA-silencing studies indicated that dUTPase might be
important in embryonic development [22]. Very recently, in planarians, silencing of dut caused lethality
in adult animals possibly due to genomic DNA fragmentation. Co-administration of the thymidylate
synthase inhibitor 5-fluoro-uracil (5-FU) resulted in more DNA breaks and earlier planarian death [23].
In Drosophila melanogaster, dUTPase silencing led to early pupal lethality suggesting a specific role
of dUTPase and uracil-DNA metabolism in metamorphosing insects [24,25]. It has been shown
that dUTPase is also essential in Arabidopsis thaliana. In these plants, reduced dUTPase activity
caused DNA damage and increased homologous recombination events. Furthermore, these plants
were extremely sensitive to 5-FU [26]. In human cell lines, several laboratories published siRNA
dUTPase-silencing studies [27–29]. These all proposed that highly efficient silencing with practically
no remaining dUTPase does not perturb the cellular phenotype under normal conditions [29]. Still, the
dUTPase-silenced cell lines showed increased sensitivity towards inhibitors of the de novo thymidylate
biosynthesis. These findings corroborated the clinical significance of dUTPase inhibition in anticancer
chemotherapies [30–32]. To our best knowledge, knock-out studies on dUTPases have not yet been
published for any mammalian species.
Motivated by the lack of knowledge in the field, we initiated dUTPase knock-out experiments in
mice. Here we report successful generation of dUTPase knock-out mice using CRISPR/Cas9-mediated
genome editing. We find that absence of dUTPase leads to early embryonic lethality. No homozygous
knock-out offspring could be observed, however, homozygous knock-out blastocysts are still viable
and can be cultured in vitro, suggesting that lethality of the dUTPase knock-out sets in around or
shortly after implantation.
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2. Materials and Methods
2.1. CRISPR Constructs
The T7 single-guide RNA (sgRNA) harboring the protospacer-adjacent motif (PAM) sequence
and the Cas9 mRNA were obtained from Sigma-Aldrich (St. Louis, MO, USA). According to our
request, the designed sgRNA targeted the first common exon of dUTPase isoforms (exon 2) on mouse
chromosome 2 (Figure 1a).
2.2. CRISPR/Cas9 Efficiency Test in Mouse Embryonic Fibroblast (MEF) Cells
Target sgRNA and Cas9 nuclease mRNA were transfected into mouse embryonic fibroblast (MEF)
cells by Lipofectamine™ 3000 Transfection Reagent (ThermoFisher Scientific, Waltham, MA, USA).
According to the manufacturer’s recommendation, 2.5 µg Cas9 mRNA and 250 ng target sgRNA were
added to the sub-confluent cultures of cells grown in six-well plates. 24 h after transfection, cells were
maintained in a fresh medium for 24 h, and then the genomic DNA was extracted with a MasterPure™
DNA Purification Kit (Epicentre, Madison, WI, USA). After DNA amplification with Cel-1-F and
Cel-1-R primers, Cel 1 cleavage assay was performed using the Transgenomic® SURVEYOR® Mutation
Detection Kit according to the manufacturer’s instructions. The primers used in this study were
synthesized by Sigma-Aldrich and are listed in Table S1.
2.3. Animals
dUTPase wild-type and heterozygous mice used in the experiments were produced and
maintained in the Animal Care Facility at the Agricultural Biotechnology Institute, National
Agricultural Research and Innovation Centre (NAIK) (FVB/N background, Envigo, UK). Animals
were housed in groups of 2–5 with free access to food and water. Animals were kept under a standard
light–dark cycle (06.00–18.00 h) at 22 ◦C. This study was carried out in strict accordance with the
recommendations and rules in the Hungarian Code of Practice for the Care and Use of Animals for
Scientific Purposes. The protocol was approved by the Animal Care and Ethics Committee of the
Agricultural Biotechnology Institute, NAIK and the Pest County’s governmental office (permission
number: PEI/001/329-4/2013). The method used for euthanasia was cervical dislocation. All efforts
were made to minimize suffering.
2.4. Micromanipulation and Detection of Gene Targeting
Microinjection was performed as described previously [33]. Briefly, mouse zygotes were collected
at 20 h after injection of human chorionic gonadotropin (hCG) from superovulated FVB/N females
mated with FVB/N males. Pronuclei were injected using a manual injector with continuous flow.
Following visualization of pronuclear swelling, the needle was pulled out through the cytoplasm,
injecting a small amount of additional RNA delivery to the cytoplasm. The microinjection mix
contained a sgRNA (Sigma-Aldrich, St. Louis, MO, USA) diluted in 10 mM Tris, 0.2 mM EDTA
(pH = 7.4) in a final concentration of 10 ng/µL and Cas9 mRNA (Trilink, San Diego, CA, USA) in
10 mM Tris, 0.2 mM EDTA (pH = 7.4) in a final concentration of 150 ng/µL. Microinjections were
finished within 2 h after zygote isolation. Injected zygotes were transferred to pseudopregnant
CD-1 females (Envigo, Huntingdon, UK). All animals born from embryo transfer were genotyped by
polymerase chain reaction (PCR) and T7 assay.
2.5. Cloning and Sequencing
Genotyping of the heterozygous founder animals was carried out by amplifying the CRISPR
target sites from genomic DNA using primers pBS-F and pBS-R (listed in Table S1), and the fragments
were cloned into SalI/EcoRI sites of vector pBluescript SK (+) (Stratagene). Twenty individual bacterial
colonies were purified with NucleoSpin® Plasmid DNA Purification Kit (MACHEREY-NAGEL GmbH
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& Co. KG (Düren, Germany), according to the manufacturer’s instructions, then DNA samples were
subjected to sequencing. Based on the sequencing results, two animals (founder #2 and #4) showed
CRISPR events, their offspring were termed (D6, M1) and D47, respectively. All DNA samples in this
study were verified by sequencing by Microsynth Seqlab GmbH.
2.6. Off-Target Analysis
Off-target effects of CRISPR/Cas9 nucleases were evaluated via the online predictor
CCTop—CRISPR/Cas9 target (https://crispr.cos.uni-heidelberg.de/) [34]. Twelve candidate loci
for the target site with high potential cleavage in the mouse genome were chosen. The selected
potential off-target sites were PCR-amplified using genomic DNA from both wild-type mice and the
founder animal #4 and evaluated by DNA sequencing. Ten of the twelve candidate off-target sites
could be analyzed. In all these cases no difference was observed (see Figure S2). Two of the candidate
off-target sites (Off-2 and Off-4) could not be evaluated due to non-specific PCR product from repetitive
elements in both the wild-type and the founder #4 samples. The information on the off-target loci
identified by the online program are shown in Table 1 and sequencing primer pairs used are listed in
Table S1.
2.7. Genotyping
The genotypes of mice were determined by PCR of the total genomic DNA extracted from mouse
tails. Genotyping of embryos was also performed by PCR either by isolating DNA from full embryos
or from outgrowth assays. All isolated samples were dissolved in a DNA lysis buffer (0.1 M Tris-HCl,
pH = 7.4, 0.2 M NaCl, 5 mM EDTA, 0.2% SDS) and DNA was extracted with phenol–chloroform.
MyTaq polymerase (Bioline) was activated at 95 ◦C for 5 min, and PCR was performed for 30 cycles
at 95 ◦C for 30 s, 64 ◦C for 30 s, and 72 ◦C for 30 s, with a final extension at 72 ◦C for 10 min
using primers Dut-gen-F and Dut-gen-R (Table S1). Genotyping from blastocysts was performed by
semi-nested PCR using 1 µL template from 30× diluted primary PCR product with primers Dut-nest-F
and Dut-gen-R (Table S1) under the same reaction conditions. DNA fragments were visualized by 1%
agarose gel electrophoresis.
2.8. Analysis of Dissected Embryos
For the analysis presented in this manuscript, D47 heterozygous males were mated with D47
heterozygous females, and embryos at various stages (3.5–9.5 dpc (days post coitum)) were collected
from pregnant D47 heterozygous females. Dissections were performed in ice-cold phosphate buffered
saline (PBS). After dissection, embryos were examined and photographed with a LeicaM205FCA-FC
fluorescent stereo microscope linked to a DFC7000-T Leica camera. The day of plug formation was
defined as embryonic day 0.5.
2.9. Analysis of Blastocyst Outgrowth
Embryos were flushed out from the uteri of pregnant mice at 3.5 dpc in M2 medium. Blastocysts
were individually cultured on 0.1% gelatin-coated, 12-well tissue culture dishes (Eppendorf),
in KO-DMEM ES cell culture medium supplemented with 1000 U/mL LIF and 20% fetal bovine
serum (HyClone), in 5% CO2 at 37 ◦C for four days. Outgrowths were photographed daily using a
LeicaM205FCA-FC fluorescent stereo microscope linked to a DFC7000-T Leica camera. On the fourth
day of culture, outgrowths were photographed, subsequently removed, and genotyped by PCR as
described above.
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2.10. Western Blot
Embryos at 10.5 dpc were dissected immediately following euthanasia of pregnant mice,
then washed with PBS and resuspended in a lysis buffer (20 mM HEPES, pH = 7.5, 420 mM NaCl,
1 mM EDTA, 2 mM dithiothreitol (DTT), 25% glycerol). Homogenization was assisted with vortex
until the tissue was sufficiently disrupted. Samples were centrifuged at 20,000× g for 15 min at
4 ◦C to remove the insoluble fraction, then the supernatant samples were boiled with SDS buffer at
95 ◦C for 5 min. Total proteins were resolved under denaturing and reducing conditions on a 12%
polyacrylamide gel and transferred to the PVDF membrane (Immobilon-P, Merck Millipore, Billerica,
MA, USA). Membranes were blocked with 5% non-fat dried milk in TBS-T (25 mM Tris-HCl, pH = 7.4,
140 mM NaCl, 3 mM KCl, 0.05% Tween-20) for 1 h at 4 ◦C and were developed against dUTPase
(1:2000, Sigma-Aldrich) and α-actin (1:1000, Sigma-Aldrich) for loading control. After applying
horseradish peroxidase-coupled secondary antibodies (Amersham Pharmacia Biotech, Piscataway, NJ,
USA), immunoreactive bands were visualized by an enhanced chemiluminescence reagent (Millipore,
Western Chemiluminescent HRP substrate), and images were captured by a Bio-Rad ChemiDoc™ MP
Imaging System. Densitometry was done using Bio-Rad Image Lab™ 6.0 (Hercules, CA, USA).
2.11. Statistical Analysis
Statistical analysis was done with a two-sample, single-tailed t-test assuming equal variance using
Microsoft Excel or was carried out with a two-sided Mann–Whitney U test. The data were considered
significant when p < 0.05 (*).
3. Results
3.1. Targeted Knock-Out of Mouse dUTPase by CRISPR/Cas9 Gene Editing
To explore the importance of dUTPase in mammalian life, we attempted to establish dUTPase
knock-out mice using CRISPR/Cas9-mediated gene editing. Figure 1 shows the outline of the applied
knock-out strategy. The respective single-guide RNA was designed to disrupt both nuclear and
mitochondrial isoforms of dUTPase (Figure 1a), which arise from a single gene (dut) on chromosome 2.
Efficiency of the CRISPR-mediated events were first assessed by the surveyor assay in mouse embryonic
fibroblast (MEF) cells (Figure 1b). We found evidence of CRISPR/Cas9-induced cleaved products and,
based on this result, we started the mouse zygote microinjection. Figure 1c shows the schematics of
gene targeting and mice generation. In the microinjection experiments, 107 embryos were flushed and
microinjected, then 76 embryos from these 107 embryos were transferred to five foster mothers. Two
foster mothers had in sum 15 offspring (resulting in a 20% survival rate). Three out of the 15 offspring
were successfully targeted by CRISPR/Cas9 based on T7 assay (20% targeted rate), and two of them
(these are numbered as #2 and #4) showed mono-allelic indels verified by sequencing. Sequencing
results from mouse #2 showed a six bp deletion and one base substitution leading to altered amino acid
sequences. Sequencing results from mouse #4 showed a 47 bp deletion leading to frameshift and early
stop codons (Figure 1d). Chromatograms of the sequencing could be found in Figure S1. Heterozygous
mouse #2 and mouse #4 were the founder (F0) animals for the downstream mouse strains. We have
termed the strain from the founder mouse #2 as (D6, M1) and the strain from the founder mouse #4 as
D47. Genotype was determined by PCR throughout the study (see ‘Materials and Methods’ section
for details). Founder mouse #2 and chimeric founder mouse #4 were then bred to a wild-type mouse
for germline transmission thus generating progeny containing the targeted gene. Homozygous and
heterozygous offspring of strain (D6, M1), as well as heterozygous offspring of strain D47 showed
no gross visually observable abnormalities and were fertile through multiple generations. Further
experiments presented in this study were conducted on F2 or even later generations of the mouse
strain D47, thereby excluding the possibility of mosaicism.
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Figure 1. Generation and assessment of CRISPR knock-out mice. (a) Schematic diagram of the dut
gene encoding the nuclear (nDut) and mitochondrial (mDut) isoforms of deoxyuridine 5′-triphosphate
nucleotidohydrolase (dUTPase). Exons are indicated with Roman numerals in rectangles, introns
are simplified as lines (for longer introns lines are broken). Guide RNA (gRNA) target site and
protospacer-adjacent motif (PAM) sequence in the first common exon of the two isoforms are underlined.
(b) Surveyor assay performed on mouse embryonic fibroblast (MEF) cells used for the detection of
indel events induced by transfection with CRISPR gRNA and Cas9 mRNA. The two lower fragments
indicate cleavage of the DNA due to CRISPR activity. These are lacking in the control while they are
visible in the transfected sample. (c) Schematic diagram showing the generation of CRISPR-targeted
knock-out mice. Fertilized oocytes microinjected with gRNA and Cas9 mRNA were implanted into
foster mothers. The resulting founders (F0) #2 and #4 were cross-bred with wild-type (WT) mice to
generate wild-type (dut +/+) and heterozygous (dut +/−) offspring (F1) containing the targeted locus
through germline transmission. (d) DNA and predicted amino acid sequence of the two heterozygous
founder mice (#2 and #4) showing CRISPR events, compared to the WT. Mouse #2 showed deletion
of six nucleotides and a C to G mutation (D6, M1) resulting in the deletion of two amino acids and
change of another two. In mouse #4, 47 nucleotides were deleted (D47) which resulted in a frameshift
mutation leading to early stop codons indicated with dashed lines. CRISPR target site including PAM
sequence is underlined.
In our CRISPR-based knock-out experiments, the target site was situated within the dut gene, as
shown in Figure 1a. The sequence of this target site was as follows: CGCGCGCGGACCCGCGGGT.
To check for potential off-target effects, we had carefully analyzed the twenty most similar sequences
to this target sequence within the mouse genome with the online predictor software CCTop [34]
(see ‘Materials and Methods’ section for details) (Table 1). In each similar sequence, at least three or
more mismatches occurred reducing the chance of off-target effects [35]. To decide whether any of the
first ten sequences may lead to off-target cleavage using the CRISPR/Cas9 method, we sequenced these
genomic segments both in the wild-type and in the founder mouse #4. We also sequenced the 16th and
18th most similar genomic segments as they were located on the same chromosome (chr2) as the dut
gene, thus, an off-target effect in these segments could be inherited together with the dut knock-out
allele. Sequences from the wild-type and the mouse #4 were identical (see Figure S2 for the sequencing
chromatograms). However, two of the candidates’ off-target sites (Off-2 and Off-4) could not be
evaluated due to non-specific PCR product in both the wild-type and the founder #4 samples. We
therefore concluded that no CRISPR-induced event could be observed at these successfully sequenced
sites, arguing for lack of off-target effects.
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Table 1. Potential off-target sites predicted by CCTop—CRISPR/Cas9 target online predictor software.
Name Coordinates MM Target Sequence PAM
Dut chr2:125247853-125247874 0 CGCGCGCGGAC[CCGCGGGT] GGG
Off-1 chr13:88680616-88680637 4 TGAGTGGGGAC[CCGCGGGT] TGG
Off-2 chr4:120746882-120746903 4 CTGGAGCGGCC[CCGCGGGT] GGG
Off-3 chr15:28025084-28025105 4 CGGCCACGGCC[CCGCGGGT] AGG
Off-4 chr11:23306808-23306829 4 GGGGCGGGGAG[CCGCGGGT] GGG
Off-5 chr2:118372992-118373013 4 CGCTGGTGGCC[CCGCGGGT] TGG
Off-6 chr5:64803646-64803667 4 ACCGCACGGAC[GCGCGGGT] GGG
Off-7 chr18:85179644-85179665 3 CGTGCGCGCAC[GCGCGGGT] GGG
Off-8 chr9:77319229-77319250 4 CGCGCTTACAC[CCGCGGGT] GGG
Off-9 chr2:104319532-104319553 3 CGCGTGCGCAC[ACGCGGGT] AGG
Off-10 chr19:36918725-36918746 4 CTCGCTGGGAC[GCGCGGGT] AGG
Off-11 chr5:75044665-75044686 4 TGGGCGCGGGC[GCGCGGGT] GGG
Off-12 chr4:152086570-152086591 4 CGCACCCAGAC[ACGCGGGT] CGG
Off-13 chr3:41563582-41563603 4 GGCGCGGGGGC[GCGCGGGT] CGG
Off-14 chr8:60640130-60640151 4 GGCGCGTGGGC[ACGCGGGT] TGG
Off-15 chr9:40192333-40192354 3 CGCGCGGGGCC[CAGCGGGT] CGG
Off-16 chr2:174438958-174438979 4 AGCGCGTGGGC[CTGCGGGT] CGG
Off-17 chr17:88792070-88792091 4 CGGGCGGGGGC[CGGCGGGT] GGG
Off-18 chr2:28641663-28641684 4 GGCACGGGGAC[CCGGGGGT] GGG
Off-19 chr17:28350853-28350874 4 GGCGGGCGGGC[CCACGGGT] GGG
Off-20 chr5:107597539-107597560 4 GGCGCGTGGAT[CGGCGGGT] AGG
The table presents the chromosomal location, the number of mismatches (MM), the target, and the adjacent PAM
sequences. The first row depicts the target site of the designed gRNA, further rows list the top 20 candidates for
off-target sites. Mismatches are indicated in red. Brackets include core sequences [34]. The genomic segments that
were successfully sequenced are shown in bold.
3.2. Analysis of Developmental Effects of dUTPase Knock-Out
To assess the genotype of the embryos and progeny from dut +/−mouse intercross breeding we
designed appropriate primers for genotyping PCR reactions. The resulting products were different
in length from the wild-type as compared to the knock-out allele in mouse strain D47 (as visualized
in Figure 2a). This semi-nested PCR method proved to be efficient for genotyping from low cell
number containing samples, like blastocysts. Dut +/+ and +/− embryos could be detected at 9.5 dpc
(Figure 2b) and were obtained by intercrossing D47 heterozygous mice. However, dut −/− embryos
could only be observed at early pre-implantation stages. We revealed that all three genotypes (+/+,
+/−, −/−) resulted in live 3.5-day-old embryos (Figure 2b).
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Figure 2. Genotyping of blastocysts. (a) Schematic representation of the used semi-nested design for
genotyping. Introns are shown in blue, exons are shown in pink, and the CRISPR target site is shown in
yellow. DNA isolated from blastocysts was subjected to PCR with primers (shown as arrows) adjacent
to the CRISPR target site. The resulting amplicon was used in a second round of PCR with the same
reverse and a nested inner forward primer to generate a 417 bp length product from the WT allele and
a 370 bp product from the D47 allele. (b) Representative image of amplicons from semi-nested PCR
visualized on agarose gel. The upper and lower band correspond to WT and D47 allele, respectively.
Full-length agarose gel is included in the Supplementary Materials (Figure S7).
Table 2 summarizes the results of the genotype analysis of the animals investigated in this study.
The data clearly showed that dut −/− knock-out cells could only be isolated in early embryonic
development at the blastocyst stage (3.5 dpc).





Postnatal 21 42 0 NA a 63
10.5 dpc 3 5 0 3 11
9.5 dpc 5 5 0 0 10
8.5 dpc 10 5 0 5 20
3.5 dpc 11 13 7 NA 31
a NA, not applicable.
3.3. Embryonic Development in the dUTPase Knock-Out as Compared to the Heterozygous and
Wild-Type Animals
To further assess early embryonic development of dUTPase knock-out embryos, we cultured
in vitro for several days of 3.5 dpc blastocysts derived from intercrosses of dut +/− mice. After
hatching, these blastocysts were attached to a gelatin-coated surface (Figure 3). Blastocyst development
was checked after one day and four days (i.e., at 4.5 and at 7.5 dpc). Attached blastocysts formed
an inner cell mass (ICM) outgrowth around which trophoblast giant cells were visible (indicated
with arrows in Figure 3a). It is shown in these pictures that the dut −/− ICM was smaller, while
we did not observe obvious changes in the heterozygotes as compared to the wild-type. Additional
phase contrast images of embryos can be found in Figure S3. Quantitative analysis of ICM and
trophectoderm (TE) regions were performed as described in the Supplementary Materials (Figure
S4). Further development of the attached embryos revealed that at 7.5 dpc, the ICM clump size was
significantly smaller in the dut −/− embryo as compared to the heterozygous (p = 0.045) and the
wild-type (p = 0.022) embryos, while ICM of the heterozygotes did not show significant difference
from the wild-type (p = 0.14) (Figure 3b). Additionally, the TE size was significantly reduced in the
dut −/− embryos as compared to the heterozygous embryos (p = 0.015) (Figure 3c). Comparison of
Biomolecules 2019, 9, 136 9 of 14
the wild-type and homozygous embryos showed a considerable reduction of the trophectoderm of
the homozygous embryos (p = 0.060), while the trophectoderm size of wild-type and heterozygous
embryos did not differ significantly (p = 0.27). These findings indicated that dUTPase deficiency
impairs outgrowth of both ICM and trophectoderm cells.
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Figure 3. Outgrowth assay of pre-implantation embryos obtained by intercrossing D47 heterozygous 
mice. (a) Phase contrast images of D47 homozygous (−/−), heterozygous (+/–), and wild-type (+/+) 
blastocysts in in vitro culture. The first column shows embryos at 3.5 dpc after flushing from oviducts. 
White arrows indicate the zona pellucida surrounding the embryos. The second and third columns 
Figure 3. Outgrowth assay of pre-implantation embryos obtained by intercrossing D47 heterozygous
mice. (a) Phase contrast i ages of 47 homozygous ( /−), heterozygous (+/−), and wild-type
(+/+) blastocysts in in vitro culture. The first column shows embryos at 3.5 dpc after flushing from
oviducts. White arrows indicate the zona pellucida surrounding the embry s. The second and third
columns show the attached embryos, one day later focusing on the trophoblast cells or the inner cell
mass (ICM) in the blastocoel. Scale bar represents 20 µm. The last column presents outgrowths after
four days in culture. Scale bar represents 100 µm. Average size of ICM (b) and trophectoderm (TE)
(c) was calculated for blastocysts of indicated genotypes. Error bars indicate standard deviation. n = 3
for (−/−), n = 5 for (+/−), and n = 2 for (+/+). Statistical analysis was done with a two-sample,
single-tailed t-test assuming equal variance using Microsoft Excel. * p < 0.05.
Next, embryos were isolated at 8.5 dpc or at 9.5 dpc for investigations at post-implantation
embryonic stages (Figure 4). No obvious changes could be seen in the development of heterozygotes
(Figure 4b,d) as compared to the wild-type (Figure 4c,e). We also observed resorbed embryos (Figure 4a,
counted in Table 2) where the genotype could not be evaluated unequivocally since the mother’s
decidual tissue could not be separated from the resorptions. No dut −/− embryos were found at these
or further stages. More images of wild-type, heterozygote, and the resorbed embryos at 8.5 dpc or at
9.5 dpc are provided in Figures S5 and S6.
To analyze dUTPase protein levels in the wild-type and heterozygous mouse, Western blot analysis
was performed on the total protein extract from dut +/+ and +/− embryos (Figure 5). dUTPase levels
were significantly reduced in the heterozygote as compared to the wild-type (p = 0.019). This finding
confirmed that the dut gene was successfully disrupted using the CRISPR/Cas9 genome editing system.
Dut −/− homozygous embryo could not be found at this embryonic stage (at 10.5 dpc).
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Figure 4. Images of embryos at 8.5 and 9.5 dpc obtained by crossing D47 heterozygous mice.
(a) Representative image of a resorbed embryo at 8.5 dpc covered by decidual tissues. The resorbed
embryo could not be genotyped as indicated with “?”. Heterozygous (+/−) (b) and wild-type (+/+)
(c) embryos at 8.5 dpc are shown. Upper panels show embryos in intact decidual tissues. Scale bar
represents 1 mm. Lower panels show the embryo dissected fr m decidual tissues. Arrows indicate the
embryonic neural f ld and the extra-embryonic amn on. Scale bar represents 250 µm. Heterozygous
(+/−) (d) and wild-type (+/+) (e) embryos at 9.5 dpc are also shown. Scale bar represents 1 mm.
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mice. Membrane was developed against dUTPase (upper part) or α-actin (lower part) as a loading 
control. Blots are marked with black frame and separated with space. Uncut scans are shown in Figure 
S8. (b) Densitometric data for dUTPase levels from Western blot normalized for α-actin. Mean values 
are represented with horizontal lines. Every data point is shown, n = 4 for (+/+) and n = 6 for (+/–). 
Statistical analysis was carried out with a two-sided Mann–Whitney U test. * p < 0.05. 
4. Discussion 
The schematic pattern of embryonic development in mice is illustrated in Figure 6. In this 
scheme, the timeline of maternal mRNA and protein degradation and the parallel zygotic genome 
activation are also indicated [36,37]. Our results showed that the dUTPase knock-out did not affect 
the first several duplication cycles and viable blastocysts could be isolated. Furthermore, isolated dut 
–/– blastocysts could grow further in in vitro cultures, although outgrowth of both the inner cell mass 
and the trophectoderm cells were impaired. However, further development following implantation 
was prevented in the homozygous knock-out embryo. 
 
Figure 6. Schematic diagram of embryonic development in mice. The red and green areas show the 
timeline of simultaneous degradation of maternal transcripts and activation of zygotic transcription. 
Arrows illustrate that homozygous knock-out embryos die shortly after implantation. 
We hypothesize that the lethality of the dUTPase knock-out in mice is probably related to the 
lack of its enzymatic function in the dut –/– embryo. It is well known from the literature that the 
dUTPase enzyme is a key protein in genome integrity, and its deficiency in bacterial, yeast, and 
Drosophila models led to increased DNA damage frequency [7,20,21,24,25]. Elevated levels of ssDNA 
and double stranded breaks were observed in these models. The underlying mechanism of the 
increased DNA damage in lack of dUTPase might be attributed to the potential expansion of the 
cellular dUTP pool that leads to increased incorporation of uracil moieties into DNA. Numerous 
Figure 5. Protein level of dUTPase in embryos at 10.5 dpc from the intercrossing of D47 heterozygous
mice. (a) Western blot displaying dUTPase protein level in wild-type (+/+) and heterozygous (+/−)
mice. Membrane was developed against dUTPase (upper part) or α-actin (lower part) as a loading
control. Blots are marked with black frame and separated with space. Uncut scans are shown in Figure
S8. (b) Densitometric data for dUTPase levels from Western blot normalized for α-actin. Mean values
are represented with horizontal lines. Every data point is shown, n = 4 for (+/+) and n = 6 for (+/−).
Statistical analysis was carried out with a two-sided Mann–Whitney U test. * p < 0.05.
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4. Discussion
The schematic pattern of embryonic development in mice is illustrated in Figure 6. In this scheme,
the timeline of maternal mRNA and protein degradation and the parallel zygotic genome activation
are also indicated [36,37]. Our results showed that the dUTPase knock-out did not affect the first
several duplication cycles and viable blastocysts could be isolated. Furthermore, isolated dut −/−
blastocysts could grow further in in vitro cultures, although outgrowth of both the inner cell mass and
the trophectoderm cells were impaired. However, further development following implantation was
prevented in the homozygous knock-out embryo.
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Figure 6. Schematic diagram of embryonic develop ent in ice. The red and green areas show the
timeline of simultaneous degradation of ater al tra scripts and activation of zygotic transcription.
Arrows illustrate that homozygous knock-out e r s i s rtl after implantation.
We hypothesize that the lethality of the dUTPase knock-out in mice is probably related to the lack
of its enzymatic function i the dut −/− embryo. It is well known fr m the literature that the dUTPase
enzyme i a ke protein in genome integrity, a d its deficiency in bacterial, yeast, and Drosophila
model led to increas DNA d mage frequency [7,20,21,24,25]. Elevated lev ls of ssDNA and double
str ed breaks wer obs rved in these mo els. The underlying mechanism of the increased DNA
damage in lack of UTPase might be attributed to the potential expansion of the cellular dUTP pool
that leads to increased incorporation of uracil moieties into DNA. Nu erous uracil moieties within the
genomic DNA may induce a hyperactive base excision process through the uracil-DNA glycosylase
enzymes [6]. Repair synthesis also occurs in the dUTP-enriched milieu therefore leading to further
genomic uracil enrichment. These circumstances transform the repair process into a hyperactive
futile cycle.
Our results also showed that at the early stages of embryonic development, until the blastocyst
stage, embryos with the dut −/− genotype were still viable. Generally, maternal storages are already
depleted at the blastocyst stage, however, the exact situation is not yet characterized for maternal
dUTPase mRNA, and protein stores. We therefore conclude that viability of the early embryonal
stages might be due to various reasons: i) Maternal source of dUTPase may be sufficiently present
in these embryonal stages, or ii) the repair mechanism relying on uracil-DNA glycosylase may not
yet be effective in these stages. Unfortunately, these aspects are also not yet studied in the literature,
necessitating further detailed molecular investigations.
We conclude that mitotic events may proceed in lack of dUTPase in mice, however, the enzyme
is indispensable for later differentiation stages. Our model will be useful in later detailed studies to
outline the molecular events leading to the observed early embryonic lethal phenotype. In addition,
combined multiple knock-outs of dut and other relevant genes are also expected to provide important
insights into developmental processes.
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